cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Arcturus Therapeutics Holdings Inc
26 own
17 watching
Current Price
$0
$0.87
(3.95%)
logo-arct
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
583.88M
52-Week High
52-Week High
31.4148
52-Week Low
52-Week Low
11.7
Average Volume
Average Volume
0.43M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization583.88M
icon52-Week High31.4148
icon52-Week Low11.7
iconAverage Volume0.43M
iconDividend Yield--
iconP/E Ratio--
What does the Arcturus Therapeutics Holdings Inc do?
Arcturus Therapeutics is developing a portfolio of mRNA therapeutics for treatment of diseases with unmet medical needs. Our hope and vision are to build transformative, life-changing medicines for patients and their families. Our team has extensive experience in the discovery and development of mRNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely position us to catalyze the next generation of mRNA medicines.
Read More
How much money does Arcturus Therapeutics Holdings Inc make?
News & Events about Arcturus Therapeutics Holdings Inc.
Business Wire
2days ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Arcturus Therapeutics, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today...
Business Wire
1month ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the...
Business Wire
1month ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that is has...
PR Newswire
1month ago
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics PR Newswire KING OF PRUSSIA, Pa., Dec. 12, 2022 CSL to access late-stage next-generation mRNA platform...
Zolmax
2 months ago
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT Get Rating) HC Wainwright raised their Q3 2023 EPS estimates for Arcturus Therapeutics in a report issued on Thursday, November 10th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings per share of $0.11 for ...
Frequently Asked Questions
Frequently Asked Questions
What is Arcturus Therapeutics Holdings Inc share price today?
plus_minus_icon
Can Indians buy Arcturus Therapeutics Holdings Inc shares?
plus_minus_icon
How can I buy Arcturus Therapeutics Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Arcturus Therapeutics Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Arcturus Therapeutics Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What percentage is Arcturus Therapeutics Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Arcturus Therapeutics Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.87
(3.95%)
logo-arct
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP
$12.37
$0.12 (0.98 %)
NURIX THERAPEUTICS INC
NURIX THERAPEUTICS INC
$13.26
$0.90 (7.28 %)
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
$12.93
$0.31 (2.46 %)
Cullinan Oncology Inc
Cullinan Oncology Inc
$11.91
$0.33 (2.85 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP
$12.37
$0.12 (0.98 %)
NURIX THERAPEUTICS INC
NURIX THERAPEUTICS INC
$13.26
$0.90 (7.28 %)
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
$12.93
$0.31 (2.46 %)
Cullinan Oncology Inc
Cullinan Oncology Inc
$11.91
$0.33 (2.85 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00